Alcohol-Induced Neuropathy in Chronic Alcoholism: Causes, Pathophysiology, Diagnosis, and Treatment Options

1.

Grochowski C, Blicharska E, Baj J, Mierzwinska A, Brzozowska K, Forma A, et al. Serum iron, magnesium, copper, and manganese levels in alcoholism: a systematic review. Molecules. 2019;24(7):1361.

PubMed Central  Google Scholar 

2.

•• Edwards S, Vendruscolo LF, Gilpin NW, Wojnar M, Witkiewitz K. Alcohol and pain: a translational review of preclinical and clinical findings to inform future treatment sstrategies. Alcohol Clin Exp Res. 2020;44(2):368–83. This study provides a comprehensive review of both preclinical and clinical findings that are related to the alcohol abuse and the induction of chronic pain.

3.

World Health Organization. Global status report on alcohol and health 2018. World Health Organization 2018; https://wwwwhoint/publications/i/item/global-status-report-on-alcohol-and-health-2018 Accessed 24 Jul 2020.

4.

Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet. 2009;373:2201–14.

CAS  PubMed  PubMed Central  Google Scholar 

5.

World Health Organization. Global status report on alcohol and health 2011. World Health Organization. 2011; https://wwwwhoint/substance_abuse/publications/alcohol_2011/en/ Accessed 34 Jul 2020.

6.

Rocco A, Compare D, Angrisani D, Sanduzzi Zamparelli M, Nardone G. Alcoholic disease: liver and beyond. World J Gastroenterol. 2014;20(40):14652–9.

CAS  PubMed  PubMed Central  Google Scholar 

7.

Ferraguti G, Pascale E, Lucarelli M. Alcohol addiction: a molecular biology perspective. Curr Med Chem. 2015;22(6):670–84.

CAS  PubMed  Google Scholar 

8.

Haas SL, Ye W, Löhr JM. Alcohol consumption and digestive tract cancer. Curr Opin Clin Nutri Metabol Care. 2012;15(5):457–67.

CAS  Google Scholar 

9.

Braillon A. Treatment of alcohol use disorders in patients with liver disease. J Hepatol. 2016;65(6):1270.

PubMed  Google Scholar 

10.

Harper KM, Knapp DJ, Criswell HE, Breese GR. Vasopressin and alcohol: a multifaceted relationship. Psychopharmacology. 2018;235(12):3363–79.

CAS  PubMed  PubMed Central  Google Scholar 

11.

Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010;29(4):437–45.

PubMed  Google Scholar 

12.

Davis BC, Bajaj JS. Effects of alcohol on the brain in cirrhosis: beyond hepatic encephalopathy. Alcohol Clin Exp Res. 2018;42(4):660–7.

PubMed  Google Scholar 

13.

Singh VK, Yadav D, Garg PK. Diagnosis and management of chronic pancreatitis. Jama. 2019;322(24):2422.

CAS  PubMed  Google Scholar 

14.

Li G, Zhu L, Cao Z, Wang J, Zhou F, Wang X, et al. A new participant in the pathogenesis of alcoholic gastritis: Pyroptosis. Cell Physiol Biochem. 2018;49(1):406–18.

CAS  PubMed  Google Scholar 

15.

Gardner JD, Mouton AJ. Alcohol effects on cardiac function. Comprehen Physiol. 2015;5(2):791–802.

16.

Gallagher C, Hendriks JM, Elliott AD, Wong CX, Rangnekar G, Middeldorp ME, et al. Alcohol and incident atrial fibrillation - a systematic review and meta-analysis. Int J Cardiol. 2017;246:46–52.

PubMed  Google Scholar 

17.

Maisch B. Alcoholic cardiomyopathy. Herz. 2016;41(6):484–93.

CAS  PubMed  PubMed Central  Google Scholar 

18.

Fernández-Sola J. The effects of ethanol on the heart: alcoholic cardiomyopathy. Nutrients. 2020;12(2):572.

PubMed Central  Google Scholar 

19.

Petroni ML, Brodosi L, Marchignoli F, Musio A, Marchesini G. Moderate alcohol intake in non-alcoholic fatty liver disease: to drink or not to drink? Nutrients. 2019;11(12):3048.

PubMed Central  Google Scholar 

20.

Arranz S, Chiva-Blanch G, Valderas-Martínez P, Medina-Remón A, Lamuela-Raventós RM, Estruch R. Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients. 2012;4(7):759–81.

CAS  PubMed  PubMed Central  Google Scholar 

21.

Cahill PA, Redmond EM. Alcohol and cardiovascular disease-modulation of vascular cell function. Nutrients. 2012;4(4):297–318.

PubMed  PubMed Central  Google Scholar 

22.

Kang YJ, Zhou Z. Zinc prevention and treatment of alcoholic liver disease. Mol Asp Med. 2005;26(4–5):391–404.

CAS  Google Scholar 

23.

Zahr NM, Pfefferbaum A. Alcohol's effects on the brain: neuroimaging results in humans and animal models. Alcohol Res. 2017;38(2):183–06.

PubMed  PubMed Central  Google Scholar 

24.

Arts N, Walvoort S, Kessels R. Korsakoff's syndrome: a critical review. Neuropsychiatr Dis Treat. 2017;13:2875–90.

PubMed  PubMed Central  Google Scholar 

25.

Chakravorty S, Chaudhary NS, Brower KJ. Alcohol dependence and its relationship with insomnia and other sleep disorders. Alcohol Clin Exp Res. 2016;40(11):2271–82.

PubMed  PubMed Central  Google Scholar 

26.

Angarita GA, Emadi N, Hodges S, Morgan PT. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract. 2016;11(1):9.

27.

•• Fama R. Introduction to the special section on alcohol: Review of cognitive, emotional, and neural deficits and recovery with sustained abstinence and treatment. Neuropsychology. 2019;33(6):757–9. This article is of high importance since it provides a comprehensive review regarding the alterations within various systems that are induced by chronic alcohol consumption as well as possible treatment strategies.

28.

Hammoud N, Jimenez-Shahed J. Chronic neurologic effects of alcohol. Clin Liver Dis. 2019;23(1):141–55.

PubMed  Google Scholar 

29.

Grochowski C, Blicharska E, Bogucki J, Proch J, Mierzwinska A, Baj J, et al. Increased aluminum content in certain brain structures is correlated with higher silicon concentration in alcoholic use disorder. Molecules. 2019;24(9):1721.

CAS  PubMed Central  Google Scholar 

30.

Schuckit MA. Alcohol-use disorders, Lancet. 2009;7;373(9662):492–501.

31.

Monte SMDL, Kril JJ. Human alcohol-related neuropathology. Acta Neuropathol. 2013;127(1):71–90.

PubMed  PubMed Central  Google Scholar 

32.

Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1997;62:310–8.

CAS  PubMed  PubMed Central  Google Scholar 

33.

Hoffman E, Staff N, Kabat B, Robb J, St. Sauver J, Klein C. A population based assessment of polyneuropathy and associated disability. American Academy of Neurology, San Diego, CA. Neurology. 2015;84(16):1644–1651.

34.

Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol. 2001;8:157–65.

CAS  PubMed  Google Scholar 

35.

Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. CONTINUUM: Lifelong Learn Neurol. 2014;20:1293–306.

Google Scholar 

36.

Katona I, Weis J. Diseases of the peripheral nerves. Handbook of Clinical Neurology Neuropathology. 2018;453–74.

37.

Cherry CL, Wadley AL, Kamerman PR. Diagnosing and treating HIV-associated sensory neuropathy: a global perspective. Pain Manag. 2016;6(2):191–9.

PubMed  Google Scholar 

38.

Straube R, Müller G, Voit-Bak K, Tselmin S, Julius U, Schatz U, et al. Metabolic and non-metabolic peripheral neuropathy: is there a place for therapeutic apheresis? Horm Metab Res. 2019;51(12):779–84.

CAS  PubMed  Google Scholar 

39.

Newton SC, Marshall S. Effects of anodyne treatment on local blood flow and cutaneous sensation of the foot in a patient with peripheral neuropathy secondary to acromegaly. Physiother Theory Pract. 2019;:1–8.

40.

Ungprasert P, Matteson EL. Neurosarcoidosis. Rheum Dis Clin N Am. 2017;43(4):593–606.

Google Scholar 

41.

Boysson HD, Guillevin L. Polyarteritis Nodosa neurologic manifestations. Neurol Clin. 2019;37(2):345–57.

PubMed  Google Scholar 

42.

Aggarwal D. Prevalence of autonomic neuropathy in patients of rheumatoid arthritis and its correlation with disease severity. J Clin Diagn Res. 2017;11(4):OC09–13.

PubMed  PubMed Central  Google Scholar 

43.

Suliga E, Kozieł D, Ciesla E, Rebak D, Głuszek-Osuch M, Głuszek S. Consumption of alcoholic beverages and the prevalence of metabolic syndrome and its components. Nutrients. 2019;11(11):2764.

CAS  PubMed Central  Google Scholar 

44.

Skórzyńska-Dziduszko KE, Kimber-Trojnar Ż, Patro-Małysza J, Olszewska A, Zaborowski T, Małecka-Massalska T. An interplay between obesity and inflammation in gestational diabetes mellitus. Curr Pharm Biotechnol. 2016;17:603–13.

PubMed  Google Scholar 

45.

Rudolph T, Farbu E. Hospital-referred polyneuropathies-causes, prevalences, clinical- and neurophysiological findings. Eur J Neurol. 2007;14:603–8.

CAS  PubMed  Google Scholar 

46.

Ho KWD, Rempe T, Jerath N, Antony A. Dorsal root ganglion stimulation as a potentially effective treatment for painful hereditary and idiopathic axonal polyneuropathy: a retrospective case series. Neuromodulation: Technol Neur Interf. 2019. https://doi.org/10.1111/ner.12924.

47.

Bechakra M, Nieuwenhoff MD, Rosmalen JV, Groeneveld GJ, Huygen FJ, Zeeuw CID, et al. Pain-related changes in cutaneous innervation of patients suffering from bortezomib-induced, diabetic or chronic idiopathic axonal polyneuropathy. Brain Res. 1730;2020:146621.

Google Scholar 

48.

Hanewinckel R, Ikram MA, Van Doorn PA. Peripheral neuropathies. Handb Clin Neurol. 2016;138:263–82.

CAS  PubMed  Google Scholar 

49.

Munukutla S, Pan G, Deshpande M, Thandavarayan RA, Krishnamurthy P, Palaniyandi SS. Alcohol toxicity in diabetes and its complications: a double trouble? Alcohol Clin Exp Res. 2016;40(4):686–97.

CAS  PubMed  Google Scholar 

50.

Sadowski A, Houck RC. Alcoholic neuropathy. [Updated 2020 Apr 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499856/.

51.

Chopra K, Tiwari V. Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol. 2012;73(3):348–62.

CAS  PubMed  Google Scholar 

52.

Noble JM, Weimer LH. Neurologic complications of alcoholism. Continuum (Minneap Minn). 2014;20:624–41.

Google Scholar 

53.

Mukherjee S. Alcoholism and its effects on the central nervous system. Curr Neurovasc Res. 2013;10(3):256–62.

CAS  PubMed  Google Scholar 

54.

Mcintosh C, Chick J. Alcohol and the nervous system. J Neurol Neurosurg Psychiatry. 2004;75(3):16–21.

Google Scholar 

55.

Monforte R, Estruch R, Valls-Solé J, Nicolás J, Villalta J, Urbano-Marquez A. Autonomic and peripheral neuropathies in patients with chronic alcoholism: a dose-related toxic effect of alcohol. Arch Neurol. 1995;52(1):45–51.

CAS  PubMed  Google Scholar 

56.

Behse F, Buchthal F. Alcoholic neuropathy: clinical, electrophysiological and biopsy findings. Ann Neurol. 1977;2:95–110.

Google Scholar 

57.

Mellion M, Gilchrist JM, de la Monte S. Alcohol-related peripheral neuropathy: nutritional, toxic, or both? Muscle Nerve. 2011;43(3):309–16.

CAS  PubMed  PubMed Central  Google Scholar 

58.

Baj J, Flieger W, Teresiński G, Buszewicz G, Sitarz E, Forma A, et al. Magnesium, calcium, potassium, sodium, phosphorus, selenium, zinc, and chromium levels in alcohol use disorder: a review. J Clin Med. 2020;9(6):1901.

留言 (0)

沒有登入
gif